MRI-derived atrophy in multiple system atrophy aligns with mitochondrial and glial gene expression patterns. [PDF]
Chougar L +19 more
europepmc +1 more source
This review explores advances in wearable and lab‐on‐chip technologies for breast cancer detection. Covering tactile, thermal, ultrasound, microwave, electrical impedance tomography, electrochemical, microelectromechanical, and optical systems, it highlights innovations in flexible electronics, nanomaterials, and machine learning.
Neshika Wijewardhane +4 more
wiley +1 more source
Cost-Effectiveness Modelling of Multiple System Atrophy for Early Health Technology Assessment. [PDF]
Grand TS +10 more
europepmc +1 more source
Neuronal-specific antibody in patients with multiple system atrophy and progressive supranuclear palsy. [PDF]
Fang MS +18 more
europepmc +1 more source
Revisiting 'hot cross bun' sign: a multicentre MRI study of 97 patients with autopsy-confirmed multiple system atrophy. [PDF]
Sugiyama A +24 more
europepmc +1 more source
The Possible Significance of Proteomics in Understanding Molecular Mechanisms of Progressive Supranuclear Palsy, Corticobasal Degeneration, Multiple System Atrophy, and Dementia with Lewy Bodies. [PDF]
Madetko-Alster N +3 more
europepmc +1 more source
Alterations of the skin microbiome in multiple system atrophy: a pilot study. [PDF]
Chen D +15 more
europepmc +1 more source
Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy. [PDF]
Vijiaratnam N +29 more
europepmc +1 more source
Fanciulli and Wenning's review (Jan. 15 issue) on multiple-system atrophy is comprehensive and up to date. In it, the authors state that the open-label administration of gabapentin could ameliorate cerebellar symptoms in single cases of this disease ...
Benoit, Peyronnet +2 more
openaire +8 more sources
Neurofilament light levels predict clinical progression and death in multiple system atrophy [PDF]
Disease-modifying treatments are currently being trialed in multiple system atrophy (MSA). Approaches based solely on clinical measures are challenged by heterogeneity of phenotype and pathogenic complexity.
Carlo Wilke +2 more
exaly +2 more sources

